Eprenetapopt
- Generic Name
- Eprenetapopt
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H17NO3
- CAS Number
- 5291-32-7
- Unique Ingredient Identifier
- Z41TGB4080
- Background
Eprenetapopt has been used in trials studying the treatment of Prostatic Neoplasms, Hematologic Neoplasms, and Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath